Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Capital Employed: 2014-2025

Historic Return on Capital Employed for Ocular Therapeutix (OCUL) over the last 11 years, with Sep 2025 value amounting to -0.66%.

  • Ocular Therapeutix's Return on Capital Employed fell 35.00% to -0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.66%, marking a year-over-year decrease of 35.00%. This contributed to the annual value of -0.55% for FY2024, which is 5.00% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Return on Capital Employed of -0.66% as of Q3 2025, which was down 11.07% from -0.59% recorded in Q2 2025.
  • In the past 5 years, Ocular Therapeutix's Return on Capital Employed registered a high of -0.23% during Q2 2024, and its lowest value of -0.90% during Q2 2023.
  • Over the past 3 years, Ocular Therapeutix's median Return on Capital Employed value was -0.52% (recorded in 2025), while the average stood at -0.53%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 98bps in 2021, then crashed by 41bps in 2023.
  • Over the past 5 years, Ocular Therapeutix's Return on Capital Employed (Quarterly) stood at -0.42% in 2021, then declined by 22bps to -0.64% in 2022, then rose by 16bps to -0.48% in 2023, then climbed by 8bps to -0.40% in 2024, then tumbled by 35bps to -0.66% in 2025.
  • Its last three reported values are -0.66% in Q3 2025, -0.59% for Q2 2025, and -0.52% during Q1 2025.